benzoxazoles has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masuda, D; Matsuzawa, Y; Yamashita, S | 1 |
| Chan, P; Hu, M; Liu, ZM; Tomlinson, B | 1 |
2 review(s) available for benzoxazoles and Metabolic Diseases
| Article | Year |
|---|---|
Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases.
Topics: Animals; Benzoxazoles; Butyrates; Dyslipidemias; Humans; Metabolic Diseases; PPAR alpha | 2019 |
Early investigational drugs targeting PPAR-α for the treatment of metabolic disease.
Topics: Animals; Benzoxazoles; Butyrates; Chalcones; Drug Design; Drugs, Investigational; Humans; Metabolic Diseases; PPAR alpha; PPAR gamma; Propionates | 2015 |